DE69121964D1 - Wachstumsinhibierender Faktor und für den wachstumsinhibierenden Faktor kodierender cDNS - Google Patents

Wachstumsinhibierender Faktor und für den wachstumsinhibierenden Faktor kodierender cDNS

Info

Publication number
DE69121964D1
DE69121964D1 DE69121964T DE69121964T DE69121964D1 DE 69121964 D1 DE69121964 D1 DE 69121964D1 DE 69121964 T DE69121964 T DE 69121964T DE 69121964 T DE69121964 T DE 69121964T DE 69121964 D1 DE69121964 D1 DE 69121964D1
Authority
DE
Germany
Prior art keywords
growth
inhibiting factor
cdna coding
protein
cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69121964T
Other languages
English (en)
Other versions
DE69121964T2 (de
Inventor
Shoji Tsuji
Tadashi Miyatake
Yoko Uchida
Yasuo Ihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2119620A external-priority patent/JP2815461B2/ja
Priority claimed from JP2410164A external-priority patent/JP2904935B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69121964D1 publication Critical patent/DE69121964D1/de
Publication of DE69121964T2 publication Critical patent/DE69121964T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69121964T 1990-05-09 1991-05-07 Wachstumsinhibierender Faktor und für den wachstumsinhibierenden Faktor kodierender cDNS Expired - Fee Related DE69121964T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2119620A JP2815461B2 (ja) 1990-05-09 1990-05-09 神経栄養活性抑性物質
JP2410164A JP2904935B2 (ja) 1990-10-19 1990-12-13 神経栄養活性抑制物質
JP41016590 1990-12-13

Publications (2)

Publication Number Publication Date
DE69121964D1 true DE69121964D1 (de) 1996-10-17
DE69121964T2 DE69121964T2 (de) 1997-03-27

Family

ID=27313865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69121964T Expired - Fee Related DE69121964T2 (de) 1990-05-09 1991-05-07 Wachstumsinhibierender Faktor und für den wachstumsinhibierenden Faktor kodierender cDNS

Country Status (4)

Country Link
US (1) US5214031A (de)
EP (1) EP0458673B1 (de)
AT (1) ATE142643T1 (de)
DE (1) DE69121964T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010568A1 (en) * 1990-12-13 1992-06-25 Shoji Tsuji Dna which codes for neurotrophic activity inhibitor and use thereof
CA2134443A1 (en) * 1992-04-27 1993-11-11 Terry C. Johnson Inhibitory factor
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
EP0594492A3 (de) * 1992-10-19 1995-05-10 Takeda Chemical Industries Ltd Wachstumsinhibierender Faktor.
US7258983B2 (en) 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
ATE339503T1 (de) * 1994-04-25 2006-10-15 Genentech Inc Cardiotrophin und verwendung davon
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse

Also Published As

Publication number Publication date
ATE142643T1 (de) 1996-09-15
US5214031A (en) 1993-05-25
DE69121964T2 (de) 1997-03-27
EP0458673A1 (de) 1991-11-27
EP0458673B1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
ES2102986T3 (es) Utilizacion de un modulador de la fosforilacion de las proteinas como medicamento en el tratamiento de la amiloidosis asociada con la enfermedad de alzheimer.
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DK0429570T3 (da) Osteoinducerende præparater
LTIP919A (en) Drugs and process for preparing thereof
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
ATE136777T1 (de) Behandlung von schlafstörungen unter verwendung bestimmter antidepressiva, z.b. nefazodon
DE69121964D1 (de) Wachstumsinhibierender Faktor und für den wachstumsinhibierenden Faktor kodierender cDNS
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
RU97105008A (ru) Способ лечения диспластического сколиоза у детей
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE206053T1 (de) Verwendung von monosialogangliosid gml oder von n-dichlor-acetyl-lyso-gml zur vorbeugung oder zur umkehrung der von einer langzeitbehandlung mit l- dopa bei der therapie von morbus parkinson induzierten neuronale degeneration
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
DK0621037T3 (da) Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler
PT768083E (pt) Sertralina para o tratamento de doentes pos-enfarte miocardico
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
ES2017618B3 (es) Procedimiento para producir sustancias que tengan sus germenes matados o que estan debilitadas en su virulencia, asi como el empleo de las mismas
DE69701258T2 (de) Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems
IT1271862B (it) Procedimento per la riconcia delle pelli conciate.
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
ITPD910013A1 (it) Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee